Zinc Oxide Nanoparticles Ameliorates Dimethylnitrosamine Induced Renal Toxicity in Rat
Abstract Dimethylnitrosamine (DMN) is an established carcinogen. It is toxic to several organs viz. liver, kidney, lungs and immune system. Several drugs have been used in the past to modulate its toxicity using experimental models. Present study was designed to investigate the effect of zinc oxide nanoparticles (ZnONPs) on renal toxicity caused by DMN in laboratory rat. Since oxidative mechanisms form etiological causing its toxicity, the proposed study focuses on amelioration of oxidative stress expressed by ZnONPs, if any. Present results show that administration of ZnONPs (50 mg/kg) to DMN (2μl/100g body weight) treated rats diminuted the concentration of malonaldehyde, H2O2 and NO in the kidney. However, GSH concentration increased after ZnONPs treatment. Results on glutathione S-transferase, glutathione peroxidase favored an antioxidative effect of ZnONPs. These results find support from diminished oxidative DNA damage manifested by ZnONPs in DMN treated rats. Histopathological results on kidney also indicate a protective effect of ZnONPs on renal toxicity of DMN. A comparison of results between control and ZnONPs treated rats suggests that ZnONPs might be toxic to renal tissue. Nevertheless, the study suggests that ZnONPs possess strong therapeutic/antioxidative potential against DMN induced renal toxicity.